IS6761A - Estrógen viðtakastillar - Google Patents

Estrógen viðtakastillar

Info

Publication number: IS6761A
Authority: IS; Iceland
Prior art keywords: estrogen receptor; receptor regulators; regulators; estrogen; receptor
Prior art date: 2000-10-19

Application number

IS6761A

Other languages

English (en)

Inventor

P. Dininno Frank

Y. Chen Helen

Kim Seongkon

Y. Wu Jane

Original Assignee

Merck & Co., Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-19

Filing date

2003-03-27

Publication date

2003-03-27

2003-03-27 Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.

2003-03-27 Publication of IS6761A publication Critical patent/IS6761A/is

Links

102000015694 estrogen receptors Human genes 0.000 title 1
108010038795 estrogen receptors Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Child & Adolescent Psychology (AREA)
Oncology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

IS6761A 2000-10-19 2003-03-27 Estrógen viðtakastillar IS6761A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US24158200P	2000-10-19	2000-10-19
PCT/US2001/042735 WO2002032377A2 (en)	2000-10-19	2001-10-15	Estrogen receptor modulators

Publications (1)

Publication Number	Publication Date
IS6761A true IS6761A (is)	2003-03-27

Family

ID=22911282

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6761A IS6761A (is)	2000-10-19	2003-03-27	Estrógen viðtakastillar

Country Status (20)

Country	Link
EP (1)	EP1333827A2 (is)
JP (1)	JP2004511502A (is)
KR (1)	KR20030042020A (is)
CN (1)	CN1469743A (is)
AU (2)	AU2002232381B2 (is)
BG (1)	BG107676A (is)
BR (1)	BR0114689A (is)
CA (1)	CA2424729A1 (is)
EA (1)	EA200300474A1 (is)
EC (1)	ECSP034558A (is)
EE (1)	EE200300153A (is)
HU (1)	HUP0303563A2 (is)
IL (1)	IL154984A0 (is)
IS (1)	IS6761A (is)
MX (1)	MXPA03003485A (is)
NO (1)	NO20031737L (is)
PE (1)	PE20021083A1 (is)
PL (1)	PL361053A1 (is)
SK (1)	SK4772003A3 (is)
WO (1)	WO2002032377A2 (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030225132A1 (en) *	2002-04-11	2003-12-04	Dininno Frank P.	Estrogen receptor modulators
SI1501819T1 (sl) *	2002-04-24	2011-01-31	Merck Sharp & Dohme	Modulatorji estrogen receptorjev
KR20140021045A (ko)	2002-05-10	2014-02-19	에프. 호프만-라 로슈 아게	골다공증 치료 및 예방용 비스포스폰산
CA2512000C (en) *	2002-12-26	2011-08-09	Eisai Co., Ltd.	Selective estrogen receptor modulator
JP5368792B2 (ja) *	2005-07-29	2013-12-18	レスバーロジックスコーポレイション	複合疾患の予防および処置のための薬学的組成物および挿入可能な医療用デバイスによるその送達
CA2627139A1 (en) *	2005-10-27	2007-05-03	Banyu Pharmaceutical Co., Ltd.	Novel benzoxathiin derivative
DK2118074T3 (en)	2007-02-01	2014-03-10	Resverlogix Corp	Compounds for the prevention and treatment of cardiovascular diseases
NZ594332A (en)	2009-01-08	2013-09-27	Resverlogix Corp	Compounds for the prevention and treatment of cardiovascular disease
KR101709492B1 (ko)	2009-03-18	2017-02-23	리스버로직스 코퍼레이션	신규한 소염제
US9757368B2 (en)	2009-04-22	2017-09-12	Resverlogix Corp.	Anti-inflammatory agents
HUE033581T2 (hu)	2010-06-10	2017-12-28	Seragon Pharmaceuticals Inc	Ösztrogén receptor modulátorok és alkalmazásaik
US8853423B2 (en)	2010-06-17	2014-10-07	Seragon Pharmaceuticals, Inc.	Indane estrogen receptor modulators and uses thereof
RU2640115C2 (ru)	2011-11-01	2017-12-26	Ресверлоджикс Корп.	Фармацевтические композиции замещенных хиназолинонов
SG11201403002RA (en)	2011-12-14	2014-07-30	Seragon Pharmaceuticals Inc	Fluorinated estrogen receptor modulators and uses thereof
US9073878B2 (en)	2012-11-21	2015-07-07	Zenith Epigenetics Corp.	Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en)	2012-11-21	2014-05-30	Rvx Therapeutics Inc.	Biaryl derivatives as bromodomain inhibitors
US9271978B2 (en)	2012-12-21	2016-03-01	Zenith Epigenetics Corp.	Heterocyclic compounds as bromodomain inhibitors
US10111885B2 (en)	2015-03-13	2018-10-30	Resverlogix Corp.	Compositions and therapeutic methods for the treatment of complement-associated diseases

2001
- 2001-10-15 CA CA002424729A patent/CA2424729A1/en not_active Abandoned
- 2001-10-15 IL IL15498401A patent/IL154984A0/xx unknown
- 2001-10-15 PL PL01361053A patent/PL361053A1/xx not_active Application Discontinuation
- 2001-10-15 EP EP01987654A patent/EP1333827A2/en not_active Withdrawn
- 2001-10-15 MX MXPA03003485A patent/MXPA03003485A/es unknown
- 2001-10-15 AU AU2002232381A patent/AU2002232381B2/en not_active Ceased
- 2001-10-15 SK SK477-2003A patent/SK4772003A3/sk unknown
- 2001-10-15 JP JP2002535616A patent/JP2004511502A/ja not_active Withdrawn
- 2001-10-15 EE EEP200300153A patent/EE200300153A/xx unknown
- 2001-10-15 BR BR0114689-0A patent/BR0114689A/pt not_active Application Discontinuation
- 2001-10-15 EA EA200300474A patent/EA200300474A1/ru unknown
- 2001-10-15 KR KR10-2003-7005518A patent/KR20030042020A/ko not_active Withdrawn
- 2001-10-15 CN CNA018176720A patent/CN1469743A/zh active Pending
- 2001-10-15 AU AU3238102A patent/AU3238102A/xx active Pending
- 2001-10-15 WO PCT/US2001/042735 patent/WO2002032377A2/en not_active Ceased
- 2001-10-15 HU HU0303563A patent/HUP0303563A2/hu unknown
2002
- 2002-04-15 PE PE2002000308A patent/PE20021083A1/es not_active Application Discontinuation
2003
- 2003-03-26 BG BG107676A patent/BG107676A/bg unknown
- 2003-03-27 IS IS6761A patent/IS6761A/is unknown
- 2003-04-15 NO NO20031737A patent/NO20031737L/no unknown
- 2003-04-17 EC EC2003004558A patent/ECSP034558A/es unknown

Also Published As

Publication number	Publication date
ECSP034558A (es)	2003-06-25
SK4772003A3 (en)	2003-08-05
NO20031737L (no)	2003-06-19
EP1333827A2 (en)	2003-08-13
PL361053A1 (en)	2004-09-20
WO2002032377A3 (en)	2002-08-22
PE20021083A1 (es)	2002-12-16
HUP0303563A2 (hu)	2004-03-01
BR0114689A (pt)	2003-07-01
WO2002032377A2 (en)	2002-04-25
AU2002232381B2 (en)	2004-11-18
MXPA03003485A (es)	2003-07-14
NO20031737D0 (no)	2003-04-15
BG107676A (bg)	2003-11-28
CN1469743A (zh)	2004-01-21
CA2424729A1 (en)	2002-04-25
KR20030042020A (ko)	2003-05-27
EE200300153A (et)	2003-06-16
AU3238102A (en)	2002-04-29
JP2004511502A (ja)	2004-04-15
EA200300474A1 (ru)	2003-10-30
IL154984A0 (en)	2003-10-31

Publication	Publication Date	Title
DE60140155D1 (de)	2009-11-26	Ortsabhängige Dienstebereitstellung
DE50100900D1 (de)	2003-12-11	Fixierelement
DE60125079D1 (de)	2007-01-25	Nähezustand basierte Service-Anpassung
CY2010014I2 (el)	2012-01-25	Πυρiδinοamiνες ως ρυθμιστες αγγειογενεσης
MA26878A1 (fr)	2004-12-20	Regulateurs de recepteurs d'adenosine
DE50113481D1 (de)	2008-02-21	Multifunktions-bedieneinrichtung
DE60108010D1 (de)	2005-02-03	Toner
FR2809999B1 (fr)	2002-09-27	Mecanisme de reglage
DE60109635D1 (de)	2005-04-28	Xyz-positioniereinrichtung
DE10085449T1 (de)	2003-01-30	Fixiervorrichtung
NO20031737L (no)	2003-06-19	Östrogenreseptormodulatorer
NO20013997D0 (no)	2001-08-16	Reseptoranalyse
DE60113760D1 (de)	2006-02-16	Synchronregelungsvorrichtung
DE60131175D1 (de)	2007-12-13	Teilezuführungseinrichtung
DK1268453T3 (da)	2006-10-23	Östrogen agonist/antagonist metabolitter
DE60004583D1 (de)	2003-09-25	Regler
DE60102861D1 (de)	2004-05-27	Toner
DE50110589D1 (de)	2006-09-14	Verstell-Vorrichtung
CY1105361T1 (el)	2010-03-03	Τετρακυκλικες ετepοενωσεις σαν ρυθμιστες υποδοχεα οιστρογονου
AU1252102A (en)	2002-05-21	Receptor
IS6692A (is)	2003-01-20	16alfa-metýl eða etýl setin estrógen
DE60135621D1 (de)	2008-10-16	Fixiergerät
DE50103946D1 (de)	2004-11-11	Verstellvorrichtung
FI991256L (fi)	2000-12-03	Apulaite tarjoilua varten
DE50106738D1 (de)	2005-08-18	Schaltwandler